Clinical trial
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
NCT00000238 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00000238 |
|---|---|
| Title | Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20 |
| Official title | Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Vermont |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Enrollment | 0 |
| Start date | Aug 1, 1997 |
| First posted | Sep 21, 1999 |
| Last update posted | Nov 20, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: